Management of locoregional stage esophageal cancer: A single center experience

Diseases of the Esophagus

Volumn 19, Issue 2, 2006, Pages 78-83

  Javle, Millind M ^a   Nwogu, C E ^a   Donohue, K A ^a   Iyer, R V ^a   Brady, W E ^a   Khemka, S V ^a   Smith, J L ^a   Demmy, T L ^a   Yang, G Y ^a   Nava, H R ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Chemoradiation; Esophageal cancer; Esophagectomy; Locoregional; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHI SQUARE TEST; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SURGICAL MORTALITY; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33645143498     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2006.00544.x     Document Type: Article

References (22)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun M J. Cancer statistics, 2003. CA Cancer J Clin 2003; 53: 5-26.
2. Walther C, Zilling T, Perfekt R, Moller T. Increasing prevalence of adenocarcinoma of the oesophagus and gastro-oesophageal junction: A study of the Swedish population between 1970 and 1997. Eur J Surg 2001; 167: 748-757.
3. Wei J T, Shaheen N. The changing epidemiology of esophageal adenocarcinoma. Semin Gastrointest Dis 2003; 14: 112-127.
4. Suntharalingam M, Moughan J, Coia L R, et al. The national practice for patients receiving radiation therapy for carcinoma of the esophagus: results of the 1996-1999 Patterns of Care Study. Int J Radiat Oncol Biol Phys 2003; 56: 981-987.
5. National Comprehensive Cancer Network. 2004 NCCN Practice guidelines. 2004. Available at: http://www.nccn.org. Accessed 3/29/04.
6. Young J L Jr, Roffers S D, Ries L A G, Fritz A G, Hurlbut A A (eds). SEER Summary Staging Manual -2000: Codes and Coding Instructions. Bethesda, MD: National Cancer Institute, NIH Pub. No. 01-4969, 2001.
7. Iyer R, Wilkinson N, Demmy T, Javle M. Controversies in the multimodality management of locally advanced esophageal cancer: evidence-based review of surgery alone and combined-modality therapy. Ann Surg Oncol 2004; 11: 665-673.
8. Herskovic A, Martz K, al-Sarraf M et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593-1598.
9. Al-Sarraf M, Martz K, Herskovic A et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: An intergroup study [published erratum appears in J Clin Oncol 1997; 15 (2): 866] J Clin Oncol 1997; 15: 277-284.
10. Ilson D H, Bains M, Kelsen D P, et al. Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer. J Clin Oncol 2003; 21: 2926-2932.
11. Rich T. Capecitabine and radiation therapy for advanced gastrointestinal malignancies. Oncology 2002; 16 (14): 27-30.
12. Bains M S, Stojadinovic A, Minsky B, et al. A phase II trial of preoperative combined-modality therapy for localized esophageal carcinoma: Initial results. J Thorac Cardiovasc Surg 2002; 124: 270-277.
13. Khushalani N I, Leichman C G, Proulx G, et al. Oxaliplatin in combination with protracted-infusion fluorouracil and radiation: Report of a clinical trial for patients with esophageal cancer. J Clin Oncol 2002; 20: 2844-2850.
14. Bedenne L, Michel P, Bouche O et al. Randomized phase III trial in locally advanced esophageal cancer: Radiochemotherapy followed by surgery versus radiochemotherapy alone (FFCD 9102) Proceedings of ASCO 2002; 21:130a-519a.
15. Stahl M, Wilke H, Walz M K et al. Randomized phase III trial in locally advanced squamous cell carcinoma (SCC) of the esophagus: Chemoradiation with and without surgery. Proceedings of ASCO 2003; 22: 250-1001.
16. Orringer M B, Marshall B, Iannettoni M D. Transhiatal esophagectomy: clinical experience and refinements. Ann Surg 1999; 230: 392-400
17. Nigro J J, DeMeester S R, Hagen J A, et al. Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy. J Thorac Cardiovasc Surg 1999; 117: 960-968.
18. Hulscher J B, van Sandick J W, de Boer A G, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002; 347: 1662-1669.
19. Luketich J, Alvelo-Rivera M, Buenaventura P et al. Minimally invasive esophagectomy: Outcomes in 222 patients. Ann Surg 2003; 238: 485-495.
20. Udagawa H, Akiyama H. Surgical treatment of esophageal cancer: Tokyo experience if the three-filed technique. Dis Esophagus 2001; 14: 110-114.
21. Kato H. Lymph node dissection for thoracic esophageal carcinoma. Two and 3 field lymph node dissection. Ann Chir Gynaecol 1995; 84: 193-199.
22. Altorki N, Kent M, Ferrara C, Prt J. Three field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 2002; 236: 177 -83.